Summit Financial, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Summit Financial, LLC

$2.54 Billion
Q3 2024

A detailed history of Summit Financial, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Summit Financial, LLC holds 6,630 shares of XBI stock, worth $595,970. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,630

Previous 7,125 6.95%

Holding current value

$595,970

Previous $660,000 0.76%

% of portfolio

0.03%

Previous 0.03%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$90.87 - $102.43 $44,980 - $50,702	-495 Reduced 6.95%	6,630 $655,000
Q2 2024 Jul 31, 2024	SELL	$82.22 - $94.12 $166,659 - $190,781	-2,027 Reduced 22.15%	7,125 $660,000
Q1 2024 Apr 24, 2024	BUY	$87.05 - $102.89 $371,616 - $439,237	4,269 Added 87.43%	9,152 $868,000
Q4 2023 Feb 05, 2024	BUY	$64.12 - $90.86 $70,596 - $100,036	1,101 Added 29.11%	4,883 $436,000
Q2 2023 Aug 11, 2023	BUY	$75.38 - $90.23 $285,087 - $341,249	3,782 New	3,782 $314,000

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.

Account

Summit Financial, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History